Back to search
Cancer-Associated Thrombosis (CAT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer-Associated Thrombosis (CAT) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cancer-Associated Thrombosis (CAT) trials you may qualify forThis study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CA…
Pulmonary embolism, the second leading cause of death in cancer patients, is effectively treated with anticoagulants. In patients with cancer-associated thrombo…
The study is classified as an observational pharmacological study, spontaneous, monocentric, and both retrospective and prospective for adult patients with a di…
This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) r…
This study is researching an experimental drug called REGN7508 (called "study drug") and will consist of 2 parts: Part 1 and Part 2. The study is focused on par…